Isofol Medical AB (publ) publishes interim report for January – September 2021
GOTHENBURG, Sweden, November 11, 2021 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January – September 2021 is now available on the company's website, www.isofolmedical.com.Third quarter, July –September 2021 · Net revenue amounted to TSEK 5,154 (18,439) and other revenue to TSEK 0 (0) · The result for the period amounted to TSEK -51,026 (-30,100) · Earnings per share amounted to SEK -0.32 (-0.36) · Cash and cash equivalents at September 30 amounted to TSEK 420,861 (153,612) January – September 2021 · Net